Foreseen Biotechnology
PrivateCompany Overview
Foreseen Biotechnology is a biotechnology company that develops a high-throughput integrated translational proteomics platform and AI-based analytics to discover novel therapeutic targets for cancer, inflammatory, autoimmune, and neurological diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Foreseen Biotechnology Comparables
Compare Foreseen Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Protai | 85% | |
| Sapient | 76% | |
| Recursion Pharmaceuticals | 74% |
Foreseen Biotechnology Funding Rounds
Historical fundraising activity
Foreseen Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nest.Bio | Accelerator |
| HongShan Capital Group (HSG) | Early Funding |
Foreseen Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Foreseen Biotechnology's valuation, stock price, and market status.
Is Foreseen Biotechnology a public or private company?
Foreseen Biotechnology is a private company.
What is the current stock price of Foreseen Biotechnology?
Foreseen Biotechnology is a private company with no public stock price. No recent secondary market data is available.
How much is Foreseen Biotechnology worth (valuation)?
Valuation information for Foreseen Biotechnology is not publicly available.
Can I buy Foreseen Biotechnology stock?
Foreseen Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Foreseen Biotechnology's last funding round?
Funding round information for Foreseen Biotechnology is not publicly available.
Who are the main investors in Foreseen Biotechnology?
Key investors in Foreseen Biotechnology include Nest.Bio, HongShan.
Will Foreseen Biotechnology IPO soon?
No public IPO plans have been announced for Foreseen Biotechnology.
How can I track Foreseen Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Foreseen Biotechnology's secondary market activity and sign up for updates.